U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Legg-Calve-Perthes disease(LCPD)

MedGen UID:
6035
Concept ID:
C0023234
Disease or Syndrome
Synonyms: Avascular necrosis of the capital femoral epiphysis; Coxa plana; Osteochondritis deformans; Perthes disease
SNOMED CT: Perthes disease - osteochondritis of the femoral head (111255008); Coxa plana (240241003); Pseudocoxalgia (111255008); Legg-Calve-Perthes disease (111255008)
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
Non-Mendelian inheritance
MedGen UID:
109109
Concept ID:
C0600599
Genetic Function
Source: Orphanet
A mode of inheritance that depends on genetic determinants in more than one gene.
 
Gene (location): COL2A1 (12q13.11)
 
HPO: HP:0005743
Monarch Initiative: MONDO:0007885
OMIM®: 150600
Orphanet: ORPHA2380

Definition

Legg-Calve-Perthes disease (LCPD) is characterized by loss of circulation to the femoral head, resulting in avascular necrosis in a growing child. Clinical pictures of the disease vary, depending on the phase of disease progression through ischemia, revascularization, fracture and collapse, and repair and remodeling of the bone. The disease occurs more frequently in boys, and most patients tend to be shorter than their peers. Both familial and isolated cases of LCPD have been reported (summary by Chen et al., 2004). [from OMIM]

Additional description

From MedlinePlus Genetics
Legg-Calvé-Perthes disease is a bone disorder that affects the hips. Usually, only one hip is involved, but in about 10 percent of cases, both hips are affected. Legg-Calvé-Perthes disease begins in childhood, typically between ages 4 and 8, and affects boys more frequently than girls.

In this condition, the upper end of the thigh bone, known as the femoral head, breaks down. As a result, the femoral head is no longer round and does not move easily in the hip socket, which leads to hip pain, limping, and restricted leg movement. The bone eventually begins to heal itself through a normal process called bone remodeling, by which old bone is removed and new bone is created to replace it. This cycle of breakdown and healing can recur multiple times. Affected individuals are often shorter than their peers due to the bone abnormalities. Many people with Legg-Calvé-Perthes disease go on to develop a painful joint disorder called osteoarthritis in the hips at an early age.  https://medlineplus.gov/genetics/condition/legg-calve-perthes-disease

Clinical features

From HPO
Short stature
MedGen UID:
87607
Concept ID:
C0349588
Finding
A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms).
Legg-Calve-Perthes disease
MedGen UID:
6035
Concept ID:
C0023234
Disease or Syndrome
Legg-Calve-Perthes disease (LCPD) is characterized by loss of circulation to the femoral head, resulting in avascular necrosis in a growing child. Clinical pictures of the disease vary, depending on the phase of disease progression through ischemia, revascularization, fracture and collapse, and repair and remodeling of the bone. The disease occurs more frequently in boys, and most patients tend to be shorter than their peers. Both familial and isolated cases of LCPD have been reported (summary by Chen et al., 2004).
Delayed skeletal maturation
MedGen UID:
108148
Concept ID:
C0541764
Finding
A decreased rate of skeletal maturation. Delayed skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVLegg-Calve-Perthes disease
Follow this link to review classifications for Legg-Calve-Perthes disease in Orphanet.

Conditions with this feature

Langer-Giedion syndrome
MedGen UID:
6009
Concept ID:
C0023003
Disease or Syndrome
Trichorhinophalangeal syndrome (TRPS) comprises TRPS I (caused by a heterozygous pathogenic variant in TRPS1) and TRPS II (caused by contiguous gene deletion of TRPS1, RAD21, and EXT1). Both types of TRPS are characterized by distinctive facial features; ectodermal features (fine, sparse, depigmented, and slow growing hair; dystrophic nails; and small breasts); and skeletal findings (short stature; short feet; brachydactyly with ulnar or radial deviation of the fingers; and early, marked hip dysplasia). TRPS II is characterized by multiple osteochondromas (typically first observed clinically on the scapulae and around the elbows and knees between ages 1 month and 6 years) and an increased risk of mild-to-moderate intellectual disability.
Legg-Calve-Perthes disease
MedGen UID:
6035
Concept ID:
C0023234
Disease or Syndrome
Legg-Calve-Perthes disease (LCPD) is characterized by loss of circulation to the femoral head, resulting in avascular necrosis in a growing child. Clinical pictures of the disease vary, depending on the phase of disease progression through ischemia, revascularization, fracture and collapse, and repair and remodeling of the bone. The disease occurs more frequently in boys, and most patients tend to be shorter than their peers. Both familial and isolated cases of LCPD have been reported (summary by Chen et al., 2004).
Trichorhinophalangeal dysplasia type I
MedGen UID:
140929
Concept ID:
C0432233
Disease or Syndrome
Trichorhinophalangeal syndrome (TRPS) comprises TRPS I (caused by a heterozygous pathogenic variant in TRPS1) and TRPS II (caused by contiguous gene deletion of TRPS1, RAD21, and EXT1). Both types of TRPS are characterized by distinctive facial features; ectodermal features (fine, sparse, depigmented, and slow growing hair; dystrophic nails; and small breasts); and skeletal findings (short stature; short feet; brachydactyly with ulnar or radial deviation of the fingers; and early, marked hip dysplasia). TRPS II is characterized by multiple osteochondromas (typically first observed clinically on the scapulae and around the elbows and knees between ages 1 month and 6 years) and an increased risk of mild-to-moderate intellectual disability.
Multiple epiphyseal dysplasia type 1
MedGen UID:
325376
Concept ID:
C1838280
Disease or Syndrome
Autosomal dominant multiple epiphyseal dysplasia (MED) presents in early childhood, usually with pain in the hips and/or knees after exercise. Affected children complain of fatigue with long-distance walking. Waddling gait may be present. Adult height is either in the lower range of normal or mildly shortened. The limbs are relatively short in comparison to the trunk. Pain and joint deformity progress, resulting in early-onset osteoarthritis, particularly of the large weight-bearing joints.
Hip dysplasia, Beukes type
MedGen UID:
333593
Concept ID:
C1840572
Disease or Syndrome
Beukes hip dysplasia (HDB) is characterized by severe progressive degenerative osteoarthritis of the hip joint in early adulthood, with underlying dysplasia confined to that region. Affected individuals are of normal stature and have no associated health problems. Symptoms of hip joint discomfort usually develop in infancy or later childhood, but may present as late as the fourth decade. Phenotypic expression is age-related and variable in severity; penetrance is incomplete and has been estimated to be 80%. The earliest primary radiographic features of HDB include bilateral shortening and broadening of the femoral neck, delayed appearance of the secondary ossification center, coxa vara, displacement of the femoral head in the acetabulum, and overgrowth of the greater trochanters. After onset of symptoms, the characteristic signs of osteoarthritis develop, including bone sclerosis, cyst formation, and narrowing of the joint space, with rapid deterioration of the joint (summary by Watson et al., 2015).
Trichorhinophalangeal syndrome, type III
MedGen UID:
349899
Concept ID:
C1860823
Disease or Syndrome
Trichorhinophalangeal syndrome (TRPS) is characterized by craniofacial and skeletal abnormalities. Craniofacial features include sparse, slowly growing scalp hair, laterally sparse eyebrows, a bulbous tip of the nose, protruding ears, long flat philtrum, and thin upper vermillion border. The most typical radiographic findings in TRPS are cone-shaped epiphyses, predominantly at the middle phalanges. Hip malformations such as coxa plana, coxa magna, or coxa vara are present in over 70% of patients. In older patients, the hip abnormalities resemble degenerative arthrosis. TRPS3 differs from TRPS1 by the presence of severe brachydactyly, due to short metacarpals, and severe short stature (summary by Ludecke et al., 2001).
Spondyloepiphyseal dysplasia tarda, autosomal dominant
MedGen UID:
355785
Concept ID:
C1866717
Disease or Syndrome
Autosomal domiant spondyloepiphyseal dysplasia tarda (autosomal dominant SEDT) is an inherited condition that affects bone growth. Signs and symptoms are generally physically apparent by puberty; however, abnormalities may be seen on X-ray at an earlier age. Affected people may have skeletal abnormalities, short stature (with a short neck and trunk, specifically), scoliosis, kyphosis, lumbar hyperlordosis (exaggerated curvature of the lower back), and early-onset progressive osteoarthritis of the hips and knees. Some cases of autosomal dominant SEDT may be caused by changes (mutations) in the COL2A1 gene. As the name suggests, the condition is inherited in an autosomal dominant manner. Treatment is based on the signs and symptoms present in each person and may include surgery and pain management strategies.
Renal tubular acidosis, distal, with nephrocalcinosis, short stature, intellectual disability, and distinctive facies
MedGen UID:
370587
Concept ID:
C1969055
Disease or Syndrome
Dyskeratosis congenita, autosomal dominant 3
MedGen UID:
462795
Concept ID:
C3151445
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
Arthrogryposis, Perthes disease, and upward gaze palsy
MedGen UID:
481939
Concept ID:
C3280309
Disease or Syndrome
Avascular necrosis of femoral head, primary, 2
MedGen UID:
1386338
Concept ID:
C4479260
Disease or Syndrome
The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are now grouped into neuromuscular disorders and skeletal dysplasias; however, the overlap within each group is considerable. Affected individuals typically have either neuromuscular or skeletal manifestations alone, and in only rare instances an overlap syndrome has been reported. The three autosomal dominant neuromuscular disorders (mildest to most severe) are: Charcot-Marie-Tooth disease type 2C. Scapuloperoneal spinal muscular atrophy. Congenital distal spinal muscular atrophy. The autosomal dominant neuromuscular disorders are characterized by a congenital-onset, static, or later-onset progressive peripheral neuropathy with variable combinations of laryngeal dysfunction (i.e., vocal fold paresis), respiratory dysfunction, and joint contractures. The six autosomal dominant skeletal dysplasias (mildest to most severe) are: Familial digital arthropathy-brachydactyly. Autosomal dominant brachyolmia. Spondylometaphyseal dysplasia, Kozlowski type. Spondyloepiphyseal dysplasia, Maroteaux type. Parastremmatic dysplasia. Metatropic dysplasia. The skeletal dysplasia is characterized by brachydactyly (in all 6); the five that are more severe have short stature that varies from mild to severe with progressive spinal deformity and involvement of the long bones and pelvis. In the mildest of the autosomal dominant TRPV4 disorders life span is normal; in the most severe it is shortened. Bilateral progressive sensorineural hearing loss (SNHL) can occur with both autosomal dominant neuromuscular disorders and skeletal dysplasias.
Avascular necrosis of femoral head, primary, 1
MedGen UID:
1639295
Concept ID:
C4551562
Disease or Syndrome
Avascular necrosis of the femoral head (ANFH) is a debilitating disease that usually leads to destruction of the hip joint in the third to fifth decade of life. The disorder is characterized by progressive pain in the groin, mechanical failure of the subchondral bone, and degeneration of the hip joint. Nearly one-half of patients require hip replacement before 40 years of age. ANFH represents a specific form of the broader disease category of osteonecrosis (summary by Mont and Hungerford, 1995). Genetic Heterogeneity of Primary Avascular Necrosis of the Femoral Head ANFH2 is caused by mutation in the TRPV4 gene (605427) on chromosome 12q24. Mutation in COL2A1 has also been found in Legg-Calves-Perthes disease (LCPD; 150600), a form of ANFH in growing children.
Trichohepatoenteric syndrome 1
MedGen UID:
1644087
Concept ID:
C4551982
Disease or Syndrome
Trichohepatoenteric syndrome (THES), generally considered to be a neonatal enteropathy, is characterized by intractable diarrhea (seen in almost all affected children), woolly hair (seen in all), intrauterine growth restriction, facial dysmorphism, and short stature. Additional findings include poorly characterized immunodeficiency, recurrent infections, skin abnormalities, and liver disease. Mild intellectual disability (ID) is seen in about 50% of affected individuals. Less common findings include congenital heart defects and platelet anomalies. To date 52 affected individuals have been reported.
Martsolf syndrome 1
MedGen UID:
1778114
Concept ID:
C5542298
Disease or Syndrome
RAB18 deficiency is the molecular deficit underlying both Warburg micro syndrome (characterized by eye, nervous system, and endocrine abnormalities) and Martsolf syndrome (characterized by similar – but milder – findings). To date Warburg micro syndrome comprises >96% of reported individuals with genetically defined RAB18 deficiency. The hallmark ophthalmologic findings are bilateral congenital cataracts, usually accompanied by microphthalmia, microcornea (diameter <10), and small atonic pupils. Poor vision despite early cataract surgery likely results from progressive optic atrophy and cortical visual impairment. Individuals with Warburg micro syndrome have severe to profound intellectual disability (ID); those with Martsolf syndrome have mild to moderate ID. Some individuals with RAB18 deficiency also have epilepsy. In Warburg micro syndrome, a progressive ascending spastic paraplegia typically begins with spastic diplegia and contractures during the first year, followed by upper-limb involvement leading to spastic quadriplegia after about age five years, often eventually causing breathing difficulties. In Martsolf syndrome infantile hypotonia is followed primarily by slowly progressive lower-limb spasticity. Hypogonadism – when present – manifests in both syndromes, in males as micropenis and/or cryptorchidism and in females as hypoplastic labia minora, clitoral hypoplasia, and small introitus.
Osteootohepatoenteric syndrome
MedGen UID:
1785846
Concept ID:
C5543557
Disease or Syndrome
Osteootohepatoenteric syndrome (OOHE) is characterized by a variable combination of bone fragility, hearing loss, cholestasis, and congenital diarrhea. Some patients also display mild developmental delay and intellectual disability (Esteve et al., 2018).

Professional guidelines

PubMed

Tuktiyeva N, Dossanov B, Sakalouski A, Syzdykbayev M, Zhunussov Y
Georgian Med News 2021 Apr;(313):127-134. PMID: 34103444
Kim YJ, Novais EN
J Pediatr Orthop 2011 Sep;31(2 Suppl):S235-40. doi: 10.1097/BPO.0b013e3182260252. PMID: 21857445
Herring JA
J Pediatr Orthop 2011 Sep;31(2 Suppl):S137-40. doi: 10.1097/BPO.0b013e318223b52d. PMID: 21857427

Recent clinical studies

Etiology

Tai TH, Wong CC
N Engl J Med 2022 Jun 9;386(23):e62. doi: 10.1056/NEJMicm2118649. PMID: 35675179
Rodríguez-Olivas AO, Hernández-Zamora E, Reyes-Maldonado E
Orphanet J Rare Dis 2022 Mar 15;17(1):125. doi: 10.1186/s13023-022-02275-z. PMID: 35292045Free PMC Article
Leroux J, Abu Amara S, Lechevallier J
Orthop Traumatol Surg Res 2018 Feb;104(1S):S107-S112. Epub 2017 Nov 16 doi: 10.1016/j.otsr.2017.04.012. PMID: 29155310
Cook PC
Pediatr Clin North Am 2014 Dec;61(6):1109-18. Epub 2014 Sep 29 doi: 10.1016/j.pcl.2014.08.002. PMID: 25439014
Kim HK
J Am Acad Orthop Surg 2010 Nov;18(11):676-86. doi: 10.5435/00124635-201011000-00005. PMID: 21041802

Diagnosis

Rodríguez-Olivas AO, Hernández-Zamora E, Reyes-Maldonado E
Orphanet J Rare Dis 2022 Mar 15;17(1):125. doi: 10.1186/s13023-022-02275-z. PMID: 35292045Free PMC Article
Goyal C, Shukla A
Pan Afr Med J 2021;39:187. Epub 2021 Jul 8 doi: 10.11604/pamj.2021.39.187.30522. PMID: 34584612Free PMC Article
Parcells BW
Pediatr Clin North Am 2020 Feb;67(1):139-152. doi: 10.1016/j.pcl.2019.09.003. PMID: 31779829
Cook PC
Pediatr Clin North Am 2014 Dec;61(6):1109-18. Epub 2014 Sep 29 doi: 10.1016/j.pcl.2014.08.002. PMID: 25439014
Schoenecker PL
Orthop Rev 1986 Sep;15(9):561-74. PMID: 3331009

Therapy

Mundluru SN, Feldman D
Bull Hosp Jt Dis (2013) 2019 Mar;77(1):53-56. PMID: 30865865
Chaudhry S, Phillips D, Feldman D
Bull Hosp Jt Dis (2013) 2014;72(1):18-27. PMID: 25150324
Kim HK
J Bone Joint Surg Am 2012 Apr 4;94(7):659-69. doi: 10.2106/JBJS.J.01834. PMID: 22488623
Little DG, Kim HK
J Pediatr Orthop 2011 Sep;31(2 Suppl):S182-8. doi: 10.1097/BPO.0b013e318223b541. PMID: 21857436
Perry DC, Hall AJ
Orthop Clin North Am 2011 Jul;42(3):279-83, v. Epub 2011 May 12 doi: 10.1016/j.ocl.2011.03.002. PMID: 21742139

Prognosis

Rodríguez-Olivas AO, Hernández-Zamora E, Reyes-Maldonado E
Orphanet J Rare Dis 2022 Mar 15;17(1):125. doi: 10.1186/s13023-022-02275-z. PMID: 35292045Free PMC Article
Leroux J, Abu Amara S, Lechevallier J
Orthop Traumatol Surg Res 2018 Feb;104(1S):S107-S112. Epub 2017 Nov 16 doi: 10.1016/j.otsr.2017.04.012. PMID: 29155310
Price CT, Joseph B
Orthop Clin North Am 2011 Jul;42(3):xi. doi: 10.1016/j.ocl.2011.04.011. PMID: 21742138
Kim HK
J Am Acad Orthop Surg 2010 Nov;18(11):676-86. doi: 10.5435/00124635-201011000-00005. PMID: 21041802
Schoenecker PL
Orthop Rev 1986 Sep;15(9):561-74. PMID: 3331009

Clinical prediction guides

Wang A, Nixon T, Martin H, Richards A, McNinch A, Alexander P, Pujari R, Bale P, Shenker N, Bearcroft P, Brown S, Blackwell A, Poulson A, Snead M
Arch Dis Child 2023 Oct;108(10):789-791. Epub 2023 Mar 7 doi: 10.1136/archdischild-2022-325059. PMID: 36882306
Parcells BW
Pediatr Clin North Am 2020 Feb;67(1):139-152. doi: 10.1016/j.pcl.2019.09.003. PMID: 31779829
Leroux J, Abu Amara S, Lechevallier J
Orthop Traumatol Surg Res 2018 Feb;104(1S):S107-S112. Epub 2017 Nov 16 doi: 10.1016/j.otsr.2017.04.012. PMID: 29155310
Chaudhry S, Phillips D, Feldman D
Bull Hosp Jt Dis (2013) 2014;72(1):18-27. PMID: 25150324
Kuo KN, Wu KW, Smith PA, Shih SF, Altiok H
J Pediatr Orthop 2011 Sep;31(2 Suppl):S168-73. doi: 10.1097/BPO.0b013e318223b50e. PMID: 21857433

Recent systematic reviews

Filtes P, Sobol K, Lin C, Anil U, Roberts T, Pargas-Colina C, Castañeda P
Bone Joint J 2024 Feb 1;106-B(2):121-127. doi: 10.1302/0301-620X.106B2.BJJ-2023-0391.R2. PMID: 38295842
Adulkasem N, Phinyo P, Tangadulrat P, Wongcharoenwatana J, Ariyawatkul T, Chotigavanichaya C, Kaewpornsawan K, Eamsobhana P
Int Orthop 2022 May;46(5):1085-1094. Epub 2022 Mar 1 doi: 10.1007/s00264-022-05352-x. PMID: 35230467
Ibrahim YH, Kersh MAAL, Fahmy H
J Pediatr Orthop B 2020 Nov;29(6):550-555. doi: 10.1097/BPB.0000000000000690. PMID: 31856037
Perry DC, Machin DM, Pope D, Bruce CE, Dangerfield P, Platt MJ, Hall AJ
Am J Epidemiol 2012 Feb 1;175(3):159-66. Epub 2012 Jan 5 doi: 10.1093/aje/kwr293. PMID: 22223709
Mahadeva D, Chong M, Langton DJ, Turner AM
Acta Orthop Belg 2010 Feb;76(1):48-57. PMID: 20306964

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...